{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:51:39Z","timestamp":1790661099560,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:p>Chronic induction of the kynurenine pathway (KP) contributes to neuroinflammation by producing the excitotoxin quinolinic acid (QUIN). This has led to significant interest in the development of inhibitors of this pathway, particularly in the context of neurodegenerative disease. However, acute spinal cord injury (SCI) also results in deleterious increases in QUIN, as secondary inflammatory processes mediated largely by infiltrating macrophages, become predominant. QUIN mediates significant neurotoxicity primarily by excitotoxic stimulation of the N-methyl-D-aspartate receptor, but other mechanisms of QUIN toxicity are known. More recent focus has assessed the contribution that neuroinflammation and modulations in the KP make in mood and psychiatric disorders with recent studies linking inflammation and modulations in the KP, to impaired cognitive performance and depressed mood in SCI patients. We hypothesize that these findings suggest that in SCI, inhibition of QUIN production and other metabolites, may have multiple therapeutic modalities and further studies investigating this are warranted. However, for central nervous system-based conditions, achieving good blood-brain-barrier permeability continues to be a limitation of current KP inhibitors.<\/jats:p>","DOI":"10.4103\/1673-5374.241446","type":"journal-article","created":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T08:20:25Z","timestamp":1539591625000},"page":"2073-2076","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":18,"title":["Inhibiting the kynurenine pathway in spinal cord injury: multiple therapeutic potentials?"],"prefix":"10.4103","volume":"13","author":[{"given":"Kelly R.","family":"Jacobs","sequence":"first","affiliation":[{"name":"Neuroinflammation Group, Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5331-8659","authenticated-orcid":false,"given":"David B.","family":"Lovejoy","sequence":"additional","affiliation":[{"name":"Neuroinflammation Group, Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260525","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12974-015-0425-2","article-title":"Targeting inflammation to influence mood following spinal cord injury: a randomized clinical trial","volume":"12","author":"Allison","year":"2015","journal-title":"J Neuroinflammation"},{"key":"R2-20260525","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/sc.2016.96","article-title":"Targeting inflammation to influence cognitive function following spinal cord injury: a randomized clinical trial","volume":"55","author":"Allison","year":"2017","journal-title":"Spinal cord"},{"key":"R3-20260525","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0006-8993(93)91167-Q","article-title":"Increased levels of the excitotoxin quinolinic acid in spinal cord following contusion injury","volume":"632","author":"Blight","year":"1993","journal-title":"Brain Res"},{"key":"R4-20260525","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/brain\/118.3.735","article-title":"Quinolinic acid accumulation and functional deficits following experimental spinal cord injury","volume":"118","author":"Blight","year":"1995","journal-title":"Brain"},{"key":"R5-20260525","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.neuropharm.2016.01.034","article-title":"Kynurenine pathway metabolites and suicidality","volume":"112","author":"Bryleva","year":"2017","journal-title":"Neuropharmacology"},{"key":"R6-20260525","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jorganchem.2015.01.005","article-title":"Iron chelation and redox chemistry of anthranilic acid and 3-hydroxyanthranilic acid: A comparison of two structurally related kynurenine pathway metabolites to obtain improved insights into their potential role in neurological disease development","volume":"782","author":"Chobot","year":"2015","journal-title":"J Organomet Chem"},{"key":"R7-20260525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2014.09.034","article-title":"The Janus faces of 3-hydroxykynurenine: Dual redox modulatory activity and lack of neurotoxicity in the rat striatum","volume":"1589","author":"Col\u00edn-Gonz\u00e1lez","year":"2014","journal-title":"Brain Res"},{"key":"R8-20260525","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neuroscience.2013.12.025","article-title":"Early modulation of the transcription factor Nrf2 in rodent striatal slices by quinolinic acid, a toxic metabolite of the kynurenine pathway","volume":"260","author":"Colin-Gonzalez","year":"2014","journal-title":"Neuroscience"},{"key":"R9-20260525","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4137\/IJTR.S4282","article-title":"On the biological importance of the 3-hydroxyanthranilic acid: anthranilic acid ratio","volume":"3","author":"Darlington","year":"2010","journal-title":"Int J Tryptophan Res"},{"key":"R10-20260525","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/npp.2012.248","article-title":"Connecting inflammation with glutamate agonism in suicidality","volume":"38","author":"Erhardt","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"R11-20260525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2014.12.045","article-title":"Macrophage activation and its role in repair and pathology after spinal cord injury","volume":"1619","author":"Gensel","year":"2015","journal-title":"Brain Res"},{"key":"R12-20260525","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1742-2094-9-40","article-title":"Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice","volume":"9","author":"Guerrero","year":"2012","journal-title":"J Neuroinflammation"},{"key":"R13-20260525","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/glia.20090","article-title":"Expression of indoleamine 2, 3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons","volume":"49","author":"Guillemin","year":"2004","journal-title":"Glia"},{"key":"R14-20260525","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40122-015-0033-y","article-title":"Management of neuropathic pain associated with spinal cord injury","volume":"4","author":"Hagen","year":"2015","journal-title":"Pain Ther"},{"key":"R15-20260525","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/2472555218757180","article-title":"Development of a rapid fluorescence-based high-throughput screening assay to identify novel kynurenine 3-monooxygenase inhibitor scaffolds","volume":"23","author":"Jacobs","year":"2018","journal-title":"SLAS Discov"},{"key":"R16-20260525","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.2174\/0929867324666170502123114","article-title":"Major developments in the design of inhibitors along the kynurenine pathway","volume":"24","author":"Jacobs","year":"2017","journal-title":"Curr Med Chem"},{"key":"R17-20260525","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/gt.2014.19","article-title":"Herpes simplex virus vector-mediated gene transfer of kynurenine aminotransferase improves detrusor overactivity in spinal cord-injured rats","volume":"21","author":"Jia","year":"2014","journal-title":"Gene Ther"},{"key":"R18-20260525","first-page":"996","article-title":"Protective effects of glucosamine-kynurenic acid after compression-induced spinal cord injury in the rat","volume":"7","author":"Korimov\u00e1","year":"2012","journal-title":"Cent Eur J Biol"},{"key":"R19-20260525","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.ajpath.2011.05.048","article-title":"The tryptophan metabolite 3-hydroxyanthranilic acid plays anti-inflammatory and neuroprotective roles during inflammation: role of hemeoxygenase-1","volume":"179","author":"Krause","year":"2011","journal-title":"Am J Pathol"},{"key":"R20-20260525","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/aur.1565","article-title":"Altered kynurenine pathway metabolism in autism: Implication for immune-induced glutamatergic activity","volume":"9","author":"Lim","year":"2016","journal-title":"Autism Res"},{"key":"R21-20260525","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1089\/08977150252932424","article-title":"Heme oxygenase-1 expression after spinal cord injury: the induction in activated neutrophils","volume":"19","author":"Liu","year":"2002","journal-title":"J Neurotrauma"},{"key":"R22-20260525","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1517\/17425255.2012.712686","article-title":"Pharmacokinetic and pharmacodynamic considerations for NMDA receptor antagonists in the treatment of chronic neuropathic pain","volume":"8","author":"Niesters","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R23-20260525","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/schbul\/sbw221","article-title":"Kynurenic acid in schizophrenia: a systematic review and meta-analysis","volume":"43","author":"Plitman","year":"2017","journal-title":"Schizophr Bull"},{"key":"R24-20260525","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neuropharm.2015.10.040","article-title":"Pharmacological kynurenine 3-monooxygenase enzyme inhibition significantly reduces neuropathic pain in a rat model","volume":"102","author":"Rojewska","year":"2016","journal-title":"Neuropharmacology"},{"key":"R25-20260525","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3389\/fphar.2018.00724","article-title":"Pharmacological inhibition of indoleamine 2,3-dioxygenase-2 and kynurenine 3-monooxygenase, enzymes of the kynurenine pathway, significantly diminishes neuropathic pain in a rat model","volume":"9","author":"Rojewska","year":"2018","journal-title":"Front Pharmacol"},{"key":"R26-20260525","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1742-2094-8-94","article-title":"Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission?","volume":"8","author":"Steiner","year":"2011","journal-title":"J Neuroinflammation"},{"key":"R27-20260525","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0014-2999(92)90179-8","article-title":"Effect of kynurenate on functional deficits resulting from traumatic spinal cord injury","volume":"218","author":"Wrathall","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"R28-20260525","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1089\/neu.2006.23.866","article-title":"4-Chloro-3-hydroxyanthranilate reduces local quinolinic acid synthesis, improves functional recovery, and preserves white matter after spinal cord injury","volume":"23","author":"Yates","year":"2006","journal-title":"J Neurotrauma"},{"key":"R29-20260525","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/sc.2014.118","article-title":"Effects of methylprednisolone and 4-chloro-3-hydroxyanthranilic acid in experimental spinal cord injury in the guinea pig appear to be mediated by different and potentially complementary mechanisms","volume":"52","author":"Yates","year":"2014","journal-title":"Spinal Cord"},{"key":"R30-20260525","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cell.2011.05.020","article-title":"Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration","volume":"145","author":"Zwilling","year":"2011","journal-title":"Cell"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01300535-201813120-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:28:41Z","timestamp":1786735721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.241446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.4103\/1673-5374.241446","relation":{},"ISSN":["1673-5374","1876-7958"],"issn-type":[{"value":"1673-5374","type":"print"},{"value":"1876-7958","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"2018-07-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}